Pilot of Mailing Buprenorphine
A Pragmatic Remote Approach to Improve Transitions of Care and Retention in Opioid Use Disorder Treatment
Medical University of South Carolina
20 participants
Apr 1, 2026
INTERVENTIONAL
Conditions
Summary
This pilot study evaluates the feasibility, acceptability, and preliminary effectiveness of mailing buprenorphine to individuals with opioid use disorder (OUD) following medical hospitalization. The intervention aims to improve retention in treatment by overcoming barriers such as transportation and pharmacy access.
Eligibility
Inclusion Criteria5
- Age ≥ 18
- English-speaking
- Diagnosed with OUD and initiated on buprenorphine during hospitalization
- Discharging to a South Carolina address with a stable mailbox
- Access to phone or computer
Exclusion Criteria3
- Active psychosis or suicidal ideation
- Severe medical or neurocognitive impairment
- Pending incarceration
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
This study examines the feasibility and preliminary effectiveness of mailing buprenorphine to overcome barriers such as transportation to obtaining buprenorphine from a pharmacy.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07421102